Research use only. Compounds discussed on this site are intended strictly for laboratory research, not for human consumption.
Adalank is an N-acetyl, C-terminal amidated derivative of Selank, a nootropic peptide originating from Russian neuropeptide research programs. The modification is intended to improve stability and extend the compound's half-life relative to standard Selank, while retaining a similar anxiolytic and cognitive-support research profile.
Selank itself has a considerably larger body of published research than Adalank, which remains a newer, less-studied derivative. Most available information on Adalank comes from supplier product pages and peptide-information sites rather than peer-reviewed literature — worth keeping in mind when evaluating any claims about it.
This compound is not currently carried by our research partner, and we haven't built out a full sourcing guide for it while that remains the case. If that changes, or if you're specifically researching Selank (the better-documented parent compound), we'd recommend starting there instead.